Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | Protein kinase B | 0.0212 | 0.6622 | 1 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.0193 | 0.5959 | 1 |
Toxoplasma gondii | AGC kinase | 0.0291 | 0.9337 | 1 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.0193 | 0.5959 | 1 |
Giardia lamblia | Kinase, AGC PKA | 0.0193 | 0.5959 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.031 | 1 | 1 |
Leishmania major | protein kinase, putative,serine/threonine protein kinase, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | serine threonine protein kinase nrc | 0.0193 | 0.5959 | 0.8303 |
Trichomonas vaginalis | AGC family protein kinase | 0.031 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0119 | 0.3378 | 0.3378 |
Echinococcus multilocularis | nervana 2 | 0.0191 | 0.5885 | 0.8113 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0212 | 0.6622 | 1 |
Leishmania major | protein kinase, putative | 0.0021 | 0 | 0.5 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.0291 | 0.9337 | 0.909 |
Trichomonas vaginalis | AGC family protein kinase | 0.01 | 0.2715 | 0.2715 |
Echinococcus multilocularis | serine threonine protein kinase nrc serine threonine protein kinase gad | 0.0193 | 0.5959 | 0.8303 |
Entamoeba histolytica | protein kinase, putative | 0.0291 | 0.9337 | 0.9337 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase | 0.0193 | 0.5959 | 0.8303 |
Entamoeba histolytica | protein kinase 2, putative | 0.0193 | 0.5959 | 0.5959 |
Echinococcus multilocularis | Glutaredoxin protein 5 | 0.0191 | 0.5885 | 0.8113 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0212 | 0.6622 | 0.6622 |
Leishmania major | protein kinase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.031 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.01 | 0.2715 | 0.2715 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0212 | 0.6622 | 1 |
Leishmania major | rac serine-threonine kinase, putative,protein kinase, putative | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0193 | 0.5959 | 0.8999 |
Leishmania major | folate/biopterin transporter, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.01 | 0.2715 | 0.2715 |
Echinococcus granulosus | nervana 2 | 0.0191 | 0.5885 | 0.8113 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.031 | 1 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0212 | 0.6622 | 0.6622 |
Trichomonas vaginalis | serine/threonine-protein kinase sgk, putative | 0.0098 | 0.2641 | 0.2641 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0212 | 0.6622 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.01 | 0.2715 | 0.2715 |
Entamoeba histolytica | protein kinase, putative | 0.031 | 1 | 1 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0191 | 0.5885 | 0.8113 |
Echinococcus granulosus | Glutaredoxin protein 5 | 0.0191 | 0.5885 | 0.8113 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.031 | 1 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0191 | 0.5885 | 0.8113 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.0291 | 0.9337 | 0.909 |
Leishmania major | serine/threonine-protein kinase a, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | nervana 2 | 0.0191 | 0.5885 | 0.8113 |
Trichomonas vaginalis | AGC family protein kinase | 0.031 | 1 | 1 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0212 | 0.6622 | 1 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0191 | 0.5885 | 0.8113 |
Trichomonas vaginalis | AGC family protein kinase | 0.031 | 1 | 1 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0212 | 0.6622 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.031 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.031 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.031 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 1.2589 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.3323 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.